Christopher Downs - 08 Apr 2024 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNSP	Option to purchase common stock	Award		+40,000			202	08 Apr 2024	Common Stock	40,000	$0.2586	Direct	F1, F2
transaction	CNSP	Restricted Stock Units	Award		+40,000			242	08 Apr 2024	Common Stock	40,000		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The options set forth in the table vest in 36 equal monthly installments over three years.
F2	Issued in connection with the reporting person's employment with the Company.
F3	Each restricted stock unit represents a contingent right to receive one share of Company common stock.
F4	The restricted stock units set forth in the table vest in eight equal quarterly installments over two years.